HK1200437A1 - Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof kcnq - Google Patents
Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof kcnqInfo
- Publication number
- HK1200437A1 HK1200437A1 HK15100723.7A HK15100723A HK1200437A1 HK 1200437 A1 HK1200437 A1 HK 1200437A1 HK 15100723 A HK15100723 A HK 15100723A HK 1200437 A1 HK1200437 A1 HK 1200437A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- kcnq
- preparation
- method therefor
- potassium channel
- novel compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
- C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/44—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110328036.9A CN103073455B (zh) | 2011-10-25 | 2011-10-25 | 一类新型的kcnq钾通道激动剂、其制备方法和用途 |
PCT/CN2012/001423 WO2013060097A1 (fr) | 2011-10-25 | 2012-10-23 | Nouveau composé utilisé comme agoniste des canaux potassiques kcnq, son procédé de préparation et son utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1200437A1 true HK1200437A1 (en) | 2015-08-07 |
Family
ID=48150177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15100723.7A HK1200437A1 (en) | 2011-10-25 | 2015-01-22 | Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof kcnq |
Country Status (9)
Country | Link |
---|---|
US (1) | US9353048B2 (fr) |
EP (1) | EP2772481B1 (fr) |
JP (1) | JP5947907B2 (fr) |
KR (1) | KR101697834B1 (fr) |
CN (1) | CN103073455B (fr) |
HK (1) | HK1200437A1 (fr) |
IN (1) | IN2014KN01113A (fr) |
SG (1) | SG11201401759QA (fr) |
WO (1) | WO2013060097A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105017085B (zh) * | 2014-04-28 | 2018-06-29 | 中国科学院上海药物研究所 | 一类kcnq钾通道激动剂、其制备方法和用途 |
RU2018147263A (ru) * | 2016-06-10 | 2020-07-10 | Сайфлуор Лайф Сайенсиз, Инк | Фторированные 2-амино-4-(замещенные амино)фенилкарбаматные производные |
WO2020157126A1 (fr) | 2019-01-29 | 2020-08-06 | Università degli Studi di Salerno | Modulateurs de canaux ioniques potassiques et leurs utilisations |
BR112023019077A2 (pt) * | 2021-03-19 | 2023-12-05 | Xyzagen Inc | Pró-fármacos de abridores de canal kv7 |
CN116478068A (zh) * | 2022-01-14 | 2023-07-25 | 中国科学院上海药物研究所 | 一种高选择性kcnq4钾通道激动剂、其制备方法和用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4200259A1 (de) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
DE19539861A1 (de) * | 1995-10-26 | 1997-04-30 | Asta Medica Ag | Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen |
JP2006520759A (ja) * | 2003-03-21 | 2006-09-14 | ハー・ルンドベック・アクチエゼルスカベット | 置換されたp−ジアミノベンゼン誘導体 |
NZ541945A (en) * | 2003-03-21 | 2009-02-28 | Lundbeck & Co As H | Substituted p-diaminobenzene derivatives |
WO2005007601A2 (fr) * | 2003-07-10 | 2005-01-27 | Achillion Pharmaceuticals, Inc. | Derives arylthio-uree substitues utilises en tant qu'inhibiteurs de la replication virale |
TWI349666B (en) | 2004-03-12 | 2011-10-01 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivatives |
UA89503C2 (uk) * | 2004-09-13 | 2010-02-10 | Х. Луннбек А/С | Заміщені похідні аніліну |
SG174095A1 (en) | 2006-08-23 | 2011-09-29 | Valeant Pharmaceuticals Int | Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
GB0800035D0 (en) * | 2008-01-02 | 2008-02-13 | Glaxo Group Ltd | Compounds |
WO2011012659A2 (fr) * | 2009-07-28 | 2011-02-03 | Medichem S.A. | 4-(4-fluorobenzylamino)-1,2-phénylèridicarbonate de diéthyle et ses sels |
-
2011
- 2011-10-25 CN CN201110328036.9A patent/CN103073455B/zh active Active
-
2012
- 2012-10-23 WO PCT/CN2012/001423 patent/WO2013060097A1/fr active Application Filing
- 2012-10-23 IN IN1113KON2014 patent/IN2014KN01113A/en unknown
- 2012-10-23 JP JP2014537451A patent/JP5947907B2/ja active Active
- 2012-10-23 US US14/353,842 patent/US9353048B2/en active Active
- 2012-10-23 SG SG11201401759QA patent/SG11201401759QA/en unknown
- 2012-10-23 KR KR1020147014008A patent/KR101697834B1/ko active IP Right Grant
- 2012-10-23 EP EP12843367.9A patent/EP2772481B1/fr active Active
-
2015
- 2015-01-22 HK HK15100723.7A patent/HK1200437A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN103073455B (zh) | 2015-08-19 |
EP2772481A4 (fr) | 2015-05-27 |
SG11201401759QA (en) | 2014-09-26 |
US9353048B2 (en) | 2016-05-31 |
JP2014532629A (ja) | 2014-12-08 |
CN103073455A (zh) | 2013-05-01 |
US20140336252A1 (en) | 2014-11-13 |
JP5947907B2 (ja) | 2016-07-06 |
WO2013060097A1 (fr) | 2013-05-02 |
IN2014KN01113A (fr) | 2015-10-16 |
EP2772481A8 (fr) | 2014-11-26 |
KR101697834B1 (ko) | 2017-01-19 |
EP2772481A1 (fr) | 2014-09-03 |
KR20140090643A (ko) | 2014-07-17 |
EP2772481B1 (fr) | 2017-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201901167B (en) | Method and compositions for cellular immunotherapy | |
ZA201403503B (en) | Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors | |
DK3323834T3 (en) | Anti-cd40 antibodies, uses and methods | |
EP2679592A4 (fr) | Nouveau composé hétérocyclique, procédé de production d'un intermédiaire de celui-ci, et application associée | |
ZA201403803B (en) | Composition,apparatus,kit and method and uses thereof | |
EP2796442A4 (fr) | Composé analogue en termes de structure à la cajanine, son procédé de préparation et son utilisation | |
EP2744331A4 (fr) | Procédés et intermédiaires pouvant être utilisés pour la préparation de macrolactames | |
EP2662378A4 (fr) | Composé imide, son procédé de production, agent épaississant pour de la graisse et composition de graisse | |
HK1213894A1 (zh) | 埃克替尼和鹽酸埃克替尼的製備方法及其中間體 | |
EP2716633A4 (fr) | Dérivé de quinazoline en tant qu'inhibiteur de tyrosine-kinase, son procédé de préparation et son application | |
EP2676965A4 (fr) | Composé aryl glycoside, son procédé de préparation et d'utilisation | |
EP2725010A4 (fr) | Amide, son procédé de préparation et ses applications | |
EP2669353A4 (fr) | Antioxydant, composition antioxydante et leur procédé de production | |
EP2573072A4 (fr) | Composé d'indénoquinolone, son procédé de préparation et son utilisation | |
EP2731429A4 (fr) | Composés, procédés de préparation et procédés d'utilisation | |
GB2492051B (en) | Channel bandwidth | |
ZA201308268B (en) | Herbicidal composition comprising pinoxaden and fluroxypyrester, and methods of use thereof | |
EP2759529A4 (fr) | Procédé de préparation de 1-palmitoyl-3-acétylglycérol et procédé de préparation de 1-palmitoyl-2-linoléoyl-3-acétylglycérol l'utilisant | |
BR112013022306A2 (pt) | método, e, composição | |
HK1200437A1 (en) | Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof kcnq | |
EP2797995A4 (fr) | Mousse, composition et procédé | |
EP2738159A4 (fr) | Composés de mercapto-benzophénone, compositions et procédés de préparation de ceux-ci | |
BR112013019224A2 (pt) | composição, e metodo | |
GB201405377D0 (en) | Compound, device and method of making same | |
EP2752419A4 (fr) | Spirobenzylamine-phosphine, son procédé de préparation et son utilisation |